Curaleaf Announces Executive Automatic Securities Disposition Plan

Rhea-AI Summary

Curaleaf (OTCQX: CURLF) announced that Chief Legal Officer Peter Clateman has extended an automatic securities disposition plan (ASDP), effective March 31, 2026, to allow orderly exercise of vested options expiring July 2027 and sale of shares to cover anticipated taxes.

Sales may begin on or about July 1, 2026 and continue for six months, will be executed by an independent broker at prevailing market prices, and were authorized before a blackout period with restrictions on amendment.

Positive

• ASDP authorized before blackout on March 31, 2026
• Independent broker to execute sales at prevailing market prices
• ASDP contains meaningful restrictions on amendment or termination

Negative

• Planned sales may add downward pressure on shares July–December 2026
• Exercise of vested options tied to shares expiring July 2027

News Market Reaction – CURLF

+0.08%

1 alert

+0.08% News Effect

On the day this news was published, CURLF gained 0.08%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

STAMFORD, Conn., April 2, 2026 /PRNewswire/ -- Curaleaf Holdings, Inc. (TSX: CURA / OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer cannabis products, today announced that effective as of March 31, 2026, Mr. Peter Clateman, the Company's Chief Legal Officer, has extended an existing automatic securities disposition plan ("ASDP") in accordance with applicable United States and Canadian securities legislation and the Company's trading policies, as previously announced by the Company on January 2, 2026. The ASDP will allow for an orderly exercise of vested options set to expire in July 2027, and the sale of a portion of the acquired subordinate voting shares in the Company (the "Subordinate Voting Shares") currently owned by Mr. Clateman to cover anticipated taxes. The Subordinate Voting Shares will be sold at prevailing market prices, and sales may commence on or about July 1, 2026 and continue over the course of a six-month period.

Sales of Subordinate Voting Shares under the ASDP will be effected by an independent securities broker in accordance with the trading parameters, price and volume limits, restrictions and other instructions set out in the ASDP. The ASDP has been authorized and established on March 31, 2026, before entering into a blackout period, in the form approved by the compensation committee of the Company and contains meaningful restrictions on the ability of Mr. Clateman to amend, suspend or terminate the applicable ASDP.

Dispositions by Mr. Clateman under the ASDP will be reported in accordance with applicable securities laws. Each such filing will bear a notation to advise readers that the disposition is related to an ASDP. Information regarding the ASDP and transactions thereunder, as the case may be, may be accessed on SEDI at www.sedi.ca.

This announcement is made pursuant to the recommended practices set forth in Staff Notice 55-317 –Automatic Securities Disposition Plans of the Canadian Securities Administrators and will be available under the Company's SEDAR profile at www.SEDAR.ca.

About Curaleaf Holdings
Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf") is a leading international provider of consumer products in cannabis with a mission to enhance lives by cultivating, sharing and celebrating the power of the plant. As a high-growth cannabis company known for quality, expertise and reliability, the Company and its brands, including Curaleaf, Select, Grassroots, Find, and Anthem provide industry-leading service, product selection and accessibility across the medical and adult use markets. Curaleaf International is powered by a strong presence in all stages of the supply chain. Its unique distribution network throughout Europe, Canada and Australasia brings together pioneering science and research with cutting-edge cultivation, extraction and production. Curaleaf is listed on the Toronto Stock Exchange under the symbol CURA and trades on the OTCQX market under the symbol CURLF. For more information, please visit https://ir.curaleaf.com.

Investor Contact:
Curaleaf Holdings, Inc.
Camilo Lyon, Chief Investment Officer
IR@curaleaf.com

Media Contact:
MATTIO Communications
MattioCuraleaf@Mattio.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/curaleaf-announces-executive-automatic-securities-disposition-plan-302733234.html

SOURCE Curaleaf Holdings, Inc.

FAQ

What does Curaleaf (CURLF) say the ASDP allows Peter Clateman to do starting July 2026?

The ASDP allows sale of shares to cover anticipated taxes and exercise of vested options. According to the company, sales may commence on or about July 1, 2026 and continue over a six-month period, executed by an independent broker at market prices.

When was Peter Clateman's ASDP for Curaleaf (CURLF) authorized and why is that timing important?

The ASDP was authorized on March 31, 2026, before a blackout period. According to the company, pre-blackout authorization aligns the plan with trading policies and regulatory recommended practices and limits mid-blackout changes.

How long will Curaleaf (CURLF) share sales under the ASDP potentially continue?

Sales may continue for a six-month period beginning around July 1, 2026. According to the company, the sales window is designed to effect orderly dispositions within defined price, volume and timing parameters.

Will Curaleaf (CURLF) disclose the transactions made under the ASDP by Peter Clateman?

Yes. Dispositions will be reported under applicable securities laws with an ASDP notation. According to the company, each filing will note the disposition relates to an automatic securities disposition plan.

What limitations does Curaleaf (CURLF) say the ASDP includes on plan changes?

The ASDP includes meaningful restrictions on Mr. Clateman's ability to amend, suspend or terminate the plan. According to the company, the plan form approved by the compensation committee restricts unilateral amendments during the term.